IRD vs VICI · rev $11.0M vs P/E 9.3, rev $3.85B
Opus Genetics, Inc. (IRD) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
IRD currently screens at market cap $35.7M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the IRD and VICI stock pages for the full models.
Not investment advice.